
Lumos Pharma LUMO
Quartalsbericht 2024-Q3
hinzugefügt 07.11.2024
Lumos Pharma P/S 2011-2026 | LUMO
P/S Jährlich Lumos Pharma
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12 | 20.1 | 362 | 849 | 14.4 | 0.48 | 1.02 | 1.06 | 1.13 | 5.9 | 850 | 143 | 22.6 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 850 | 0.48 | 176 |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
105 | $ 0.88 | -2.07 % | $ 6.47 M | ||
|
Genfit SA
GNFT
|
1.96 K | - | 2.54 % | $ 160 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
3.33 | $ 22.67 | 1.66 % | $ 3.76 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
AIkido Pharma
AIKI
|
0.935 | - | 1.93 % | $ 17.4 M | ||
|
Applied Therapeutics
APLT
|
54.1 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
1.34 | - | 17.91 % | $ 11.1 M | ||
|
BioNTech SE
BNTX
|
35.7 | $ 102.06 | - | $ 27.2 B | ||
|
BioDelivery Sciences International
BDSI
|
1.85 | - | -4.8 % | $ 255 M | ||
|
Aquestive Therapeutics
AQST
|
10.5 | $ 4.09 | -0.24 % | $ 437 M | ||
|
Arcutis Biotherapeutics
ARQT
|
9.15 | $ 23.29 | -0.56 % | $ 2.96 B | ||
|
Autolus Therapeutics plc
AUTL
|
4.27 | $ 1.48 | 4.23 % | $ 394 M | ||
|
AstraZeneca PLC
AZN
|
2.17 | - | - | $ 96.9 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
759 | $ 2.91 | 0.34 % | $ 4.79 M | ||
|
BeiGene, Ltd.
BGNE
|
66.4 | - | 0.49 % | $ 251 B | ||
|
Evogene Ltd.
EVGN
|
71.3 | $ 0.79 | 1.28 % | $ 27.9 M | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
bluebird bio
BLUE
|
2.27 | - | - | $ 546 M | ||
|
Cara Therapeutics
CARA
|
2.58 | - | -3.03 % | $ 260 M | ||
|
CASI Pharmaceuticals
CASI
|
36.1 | - | - | $ 35.4 M | ||
|
BioXcel Therapeutics
BTAI
|
24 | $ 1.06 | -2.75 % | $ 12.9 M | ||
|
ChemoCentryx
CCXI
|
0.0564 | - | - | $ 3.74 B | ||
|
Cabaletta Bio
CABA
|
50.3 M | $ 2.86 | -1.72 % | $ 287 M | ||
|
Cidara Therapeutics
CDTX
|
116 | - | - | $ 1.41 B |